Emi Kamiyama Selected Research

Emi Kamiyama Research Topics

4	Neoplasms (Cancer) 11/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Animal Disease Models 05/2012
1	Arthritis (Polyarthritis) 05/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2012
1	Adenocarcinoma 01/2010

2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2009 - 12/2007
1	Ritonavir (Norvir)FDA Link 11/2021
1	trastuzumab deruxtecanIBA 11/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	AntigensIBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Erythropoietin FDA Link 01/2019
1	firuglipelIBA 08/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	patritumabIBA 01/2017
1	CS-2100IBA 05/2012
1	Digoxin (Digitek)FDA LinkGeneric 01/2010
1	Adenosine Triphosphatases (ATPase)IBA 01/2010
1	Verapamil (Calan)FDA LinkGeneric 01/2010
1	Multidrug Resistance-Associated Protein 2IBA 09/2009
1	olmesartanIBA 12/2007
1	Multidrug Resistance-Associated ProteinsIBA 12/2007

1	Drug Therapy (Chemotherapy) 01/2017